Applying Biologic Advances in Multiple Myeloma to Clinical Practice

Gareth J. Morgan, MD, of the University of Arkansas for Medical Sciences in Little Rock, Arkansas, discusses the biologic advances in multiple myeloma, and how identified mutations and pathways can offer opportunities for patients to receive targeted therapies.

 Dr. Morgan gave a presentation during an education session at the 2017 ASCO Meeting entitled, "Are We Integrating Biologic Advances in Multiple Myeloma Into Clinical Practice"?